Xvivo Perfusion AB (publ) (FRA:3XV)

Xvivo Perfusion AB Statistics

Total Valuation

FRA:3XV has a market cap or net worth of EUR 673.35 million. The enterprise value is 657.46 million.

Market Cap	673.35M
Enterprise Value	657.46M

Important Dates

The last earnings date was Tuesday, January 27, 2026.

Earnings Date	Jan 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	31.50M
Shares Outstanding	n/a
Shares Change (YoY)	-0.29%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.42%
Owned by Institutions (%)	28.10%
Float	25.06M

Valuation Ratios

The trailing PE ratio is 289.60 and the forward PE ratio is 61.42.

PE Ratio	289.60
Forward PE	61.42
PS Ratio	8.97
PB Ratio	3.45
P/TBV Ratio	4.98
P/FCF Ratio	n/a
P/OCF Ratio	72.10
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	282.76
EV / Sales	8.53
EV / EBITDA	50.01
EV / EBIT	78.37
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.77, with a Debt / Equity ratio of 0.06.

Current Ratio	5.77
Quick Ratio	3.68
Debt / Equity	0.06
Debt / EBITDA	0.90
Debt / FCF	n/a
Interest Coverage	1.77

Financial Efficiency

Return on equity (ROE) is 1.18% and return on invested capital (ROIC) is 2.97%.

Return on Equity (ROE)	1.18%
Return on Assets (ROA)	2.31%
Return on Invested Capital (ROIC)	2.97%
Return on Capital Employed (ROCE)	3.92%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	379,022
Profits Per Employee	11,743
Employee Count	198
Asset Turnover	0.34
Inventory Turnover	0.89

Taxes

In the past 12 months, FRA:3XV has paid 1.24 million in taxes.

Income Tax	1.24M
Effective Tax Rate	34.74%

Stock Price Statistics

The stock price has decreased by -42.99% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-42.99%
50-Day Moving Average	17.33
200-Day Moving Average	19.90
Relative Strength Index (RSI)	70.59
Average Volume (20 Days)	15

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:3XV had revenue of EUR 75.05 million and earned 2.33 million in profits. Earnings per share was 0.07.

Revenue	75.05M
Gross Profit	55.39M
Operating Income	8.17M
Pretax Income	3.56M
Net Income	2.33M
EBITDA	12.80M
EBIT	8.17M
Earnings Per Share (EPS)	0.07

Balance Sheet

The company has 26.99 million in cash and 11.52 million in debt, with a net cash position of 15.47 million.

Cash & Cash Equivalents	26.99M
Total Debt	11.52M
Net Cash	15.47M
Net Cash Per Share	n/a
Equity (Book Value)	195.29M
Book Value Per Share	6.20
Working Capital	52.56M

Cash Flow

Operating Cash Flow	9.34M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 73.81%, with operating and profit margins of 10.88% and 3.10%.

Gross Margin	73.81%
Operating Margin	10.88%
Pretax Margin	4.75%
Profit Margin	3.10%
EBITDA Margin	17.05%
EBIT Margin	10.88%
FCF Margin	n/a

Dividends & Yields

FRA:3XV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.29%
Shareholder Yield	0.29%
Earnings Yield	0.35%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:3XV has an Altman Z-Score of 20.94 and a Piotroski F-Score of 5.

Altman Z-Score	20.94
Piotroski F-Score	5